Oregon doctors could provide ibogaine to eligible adults with certain mental health or substance use disorders under treatment safeguards, while federal law would still apply.
Adults able to make and communicate health care decisions could receive ibogaine if their doctor believes it may help certain diagnosed disorders. Treatment would require a controlled setting with a provider experienced in managing heart complications available on site.
Ibogaine used under the treatment rules would fall outside Oregon's drug-control laws. Doctors could not face Oregon Medical Board discipline for providing that treatment, but federal law would still apply.
The doctor primarily responsible for a patient's care could provide ibogaine when the doctor believes it may help the patient's diagnosed disorder. Oregon-licensed doctors could treat patients age 18 or older with diagnosed post-traumatic stress disorder, major depressive disorder, anxiety disorder, or substance use disorder. The doctor must believe the patient can make and communicate health care decisions, directly or through someone familiar with how the patient communicates. Treatment must occur in a controlled setting designed around the patient's needs, with a provider experienced in managing heart complications available on site. Federal law would still apply. If enacted, these treatment provisions would begin January 1, 2027.
Oregon would exclude qualifying ibogaine use from its definition of a controlled substance, a drug covered by state drug-control laws. These protections would cover ibogaine treatment under the bill's rules and the Oregon-licensed doctors responsible for that care. The drug-law exception would apply only when ibogaine is obtained, provided, and consumed under the treatment rules. The Oregon Medical Board could not discipline a doctor for providing ibogaine under those rules. These protections would not excuse violations of federal law or block federal enforcement. If enacted, the drug-law exception and protection from discipline would begin January 1, 2027.
No hearings or votes scheduled.